Insiders Are Betting on MVC Capital, Inc. (MVC). Wonder Why?

Last week, MVC Capital, Inc. (NYSE:MVC)’s stock experienced several insider trades. On Wednesday, Jan. 15th, Robert Knapp, Board Director, added 31,006 shares to his holdings, having paid a price of $13.77 per share. On Thursday, Jan. 16th, he –once again- purchased the company’s stock, this time buying 4,876 shares at a price of $13.87 per share. After the reported transactions, he owns 35,882 shares, indirectly, through a separately managed account and a private fund in which Mr. Knapp is a Principal. In addition, he holds 300,765.37 shares through Ironsides Holdings LLC, which is fully-owned by him.

MVC Capital, Inc. (NYSE:MVC)

“MVC Capital, Inc., is an externally managed, non-diversified, closed-end management investment company.” (Morningstar) As it seeks to maximize returns, it holds one of the leading returns on asset in its industry (7%, vs. an industry mean of 1.2%). In addition, MVC Capital, Inc. (NYSE:MVC)’s stock trades at only 8.9 times its sales and 0.8 times its book values, compared to industry averages of 22.9 x P/E and 2.0 x P/B.

Not only Mr. Knapp increased his bet on MVC Capital, Inc. (NYSE:MVC) last week. Another insider that seems to see value in this stock is W Bruce Shewmaker, Managing Director, who added 500 shares to his holdings last Thursday.*He now owns 22,865.72 shares of common stock.

In addition to these insiders, several funds are placing their bets on MVC Capital, Inc. (NYSE:MVC)´s growth –which seems quite smart, since analysts expect it to deliver average annual EPS growth rates around 15% over the next five years. Phillip Goldstein, Andrew Dakos and Steven Samuels´ Bulldog Investors hold 1.35 million company shares to its portfolio. Their stake amounts for more than 7% of the fund’s total holdings. Another prominent investor worth mentioning is Chuck Royce, who is the second-largest hedge fund bull on MVC Capital, Inc. (NYSE:MVC), and owns 1.13 million shares.

* Mr. Shewmaker reported several transactions, both purchases and sales, on this date, but the final balance was an increase in his position by 500 shares. He paid about $13.83 per share.


Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

Zix Corporation (ZIXI): Small-Cap, Small Bets

Insiders and Funds Bet on United States Steel Corporation (X)

Insiders Like Oiltanking Partners LP (OILT) Although Hedge Funds Don’t

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!